We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Fujifilm Showcases DRI-CHEM NX700 Dry Chemistry Analyzer

By LabMedica International staff writers
Posted on 07 Feb 2018
Fujifilm Corporation (Tokyo, Japan) showcased its new generation dry chemistry analyzer series, DRI-CHEM NX700, which can perform multiple test parameters of clinical chemistry, at MEDLAB Middle East 2018.
 
Fujifilm is a pioneer in diagnostic imaging and information systems for healthcare facilities and also provides Point-of-Care Testing products for healthcare providers who need immediate clinical test results. More...
At MEDLAB Middle East 2018, the world’s largest attended laboratory & IVD exhibition and conference held in Dubai, UAE from February 5-8, 2018, Fujifilm showcased its DRI-CHEM NX700 dry chemistry analyzer series which offers a high processing speed of 190 tests per hour and makes it possible to set five samples at the same time.
 
Equipped with STAT functionality to accommodate emergency interrupt measurement, the DRI-CHEM NX700 does not require pre-treatment of sample or calibration using the QC card system. It offers easy operations with a touch screen and intuitive new software, along with enhanced connectivity features and HL7 support. The DRI-CHEM NX700 dry chemistry analyzer series is patient-friendly as it requires a testing microsample of only 6 μL and 10 μL per test. Featuring a new design with a compact size and smaller foot print, it allows for the use of different range of sample tubes.
 

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.